WPI 3587 Pill - white capsule/oblong
Pill with imprint WPI 3587 is White, Capsule/Oblong and has been identified as Armodafinil 250 mg. It is supplied by Watson Laboratories, Inc.
Armodafinil is used in the treatment of Shift Work Sleep Disorder; Obstructive Sleep Apnea/Hypopnea Syndrome; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3587
Armodafinil
- Imprint
- WPI 3587
- Strength
- 250 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3587
More about armodafinil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (435)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.